Last reviewed · How we verify

NCT04771156

Ketorolac in Palatoplasty

Recruiting now Phase 4 Last updated 19 February 2026
What this trial tests

Phase 4 trial testing Ketorolac in Cleft Lip and Palate in 74 participants. Currently enrolling.

Timeline
17 September 2021
Primary endpoint
1 March 2027
1 April 2027

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhasePhase 4
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment74
Start date17 September 2021
Primary completion1 March 2027
Estimated completion1 April 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

6 Months and older, any sex, with Cleft Lip and Palate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ketorolac

Trials testing the same drug.

Other recruiting trials for Cleft Lip and Palate

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04771156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing